인바이츠벤처스

Invites Ventures, established in 2019, is a Venture Capital with New Technology Venture Capital Business license (“Shinkisa” license).

Invites Ventures is wholly owned by CG Invites (KOSDAQ listed) and its focal area of investment was Biotech (primarily new drug pipeline) however, as of current, its portfolio has spanned beyond that of Biotech and has exposures in non-bio areas such as Deep Tech (application used for defense sector) and Personal Mobility to name a few.

Furthermore, overall portfolio is not necessarily bound within Korea but has presence in U.S and Japan. Invites Ventures is continuously seeking for investment opportunities with high growth prospect sectors (Artificial Intelligence, Innovative Medical Devices, Digital Healthcare and etc).

Invites Ventures strives not only to be best but aspires to be better. We are agile and open to innovative ideas that are in need capital. We crave to bring positive impact to the world and wish to be successful together with the founders.